IL106217A - Pharmaceutical compositions containing organic nitrites for vasodilator therapy - Google Patents

Pharmaceutical compositions containing organic nitrites for vasodilator therapy

Info

Publication number
IL106217A
IL106217A IL106217A IL10621793A IL106217A IL 106217 A IL106217 A IL 106217A IL 106217 A IL106217 A IL 106217A IL 10621793 A IL10621793 A IL 10621793A IL 106217 A IL106217 A IL 106217A
Authority
IL
Israel
Prior art keywords
nitrite
dosage form
nitrites
composition
organic
Prior art date
Application number
IL106217A
Other languages
English (en)
Other versions
IL106217A0 (en
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of IL106217A0 publication Critical patent/IL106217A0/xx
Publication of IL106217A publication Critical patent/IL106217A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL106217A 1992-07-02 1993-07-02 Pharmaceutical compositions containing organic nitrites for vasodilator therapy IL106217A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/908,224 US5278192A (en) 1992-07-02 1992-07-02 Method of vasodilator therapy for treating a patient with a condition

Publications (2)

Publication Number Publication Date
IL106217A0 IL106217A0 (en) 1993-11-15
IL106217A true IL106217A (en) 1998-04-05

Family

ID=25425396

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106217A IL106217A (en) 1992-07-02 1993-07-02 Pharmaceutical compositions containing organic nitrites for vasodilator therapy

Country Status (19)

Country Link
US (2) US5278192A (fr)
EP (1) EP0604642A1 (fr)
JP (1) JP2729333B2 (fr)
KR (1) KR0170789B1 (fr)
CN (1) CN1086997A (fr)
AU (1) AU667948B2 (fr)
CA (1) CA2116785C (fr)
CZ (1) CZ39894A3 (fr)
HU (1) HUT70501A (fr)
IL (1) IL106217A (fr)
MX (1) MX9303982A (fr)
NO (1) NO305886B1 (fr)
NZ (1) NZ254490A (fr)
OA (1) OA09890A (fr)
PL (1) PL302613A1 (fr)
SK (1) SK23594A3 (fr)
TW (1) TW261530B (fr)
WO (1) WO1994001103A1 (fr)
ZA (1) ZA934771B (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5973011A (en) * 1994-03-30 1999-10-26 Isis Pharma Gmbh Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5665077A (en) * 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US5658936A (en) * 1995-09-18 1997-08-19 Brigham & Women's Hospital, Inc. Enhancement of erectile function with renin-angiotensin system inhibitors
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6258032B1 (en) * 1997-01-29 2001-07-10 William M. Hammesfahr Method of diagnosis and treatment and related compositions and apparatus
AU2252297A (en) * 1996-01-31 1997-08-22 Technology Licensing Co., L.L.C. Method of diagnosis and treatment and related compositions and apparatus
GB9608408D0 (en) 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5958884A (en) * 1997-04-11 1999-09-28 The Brigham And Women's Hospital, Inc. Compositions and methods for treating erectile dysfunction
US6191156B1 (en) 1997-04-11 2001-02-20 The Brigham And Women's Hospital, Inc. Compositions and methods for treating bladder dysfunction
ZA989356B (en) * 1997-10-16 1998-11-16 Isis Pharma Gmbh Pharmaceutical preparations
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
US7045152B2 (en) * 1999-09-08 2006-05-16 Duke University Treating pulmonary disorders with gaseous agent causing repletion of GSNO
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
AU7007001A (en) 2000-06-22 2002-01-02 Nitromed Inc Nitrosated and nitrosylated taxanes, compositions and methods of use
BRPI0113085B1 (pt) * 2000-08-11 2017-09-19 R. Whitlock David Preparation to be applied to a surface of an individual understanding ammonia oxidizing bacteria that metabolize transparation, and clothing article
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
AU2002258798A1 (en) * 2001-04-13 2002-10-28 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US20040225275A1 (en) * 2001-08-02 2004-11-11 Reynolds James Dixon Fetal physiology during maternal surgery or diagnosis
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
AU2003222569A1 (en) * 2002-01-11 2003-07-24 Whitlock, David R. Compositions including ammonia oxidizing bacteria and methods of using same
US7691907B2 (en) 2002-03-06 2010-04-06 Duke University Methods and composition based on discovery of metabolism of nitroglycerin
US7776925B2 (en) * 2002-03-06 2010-08-17 Duke University Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
KR101030943B1 (ko) 2002-05-21 2011-04-28 씨브이 쎄러퓨틱스, 인코포레이티드 당뇨병 치료를 위한 라놀라진 등의 부분적 지방산 산화저해제 투여
US8822473B2 (en) * 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
US6936639B2 (en) * 2002-08-21 2005-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxyl progenitors in the treatment of heart failure
WO2005063221A1 (fr) * 2003-12-19 2005-07-14 Duke University Mesure de l'activite vasodilatatrice d'echantillons de sang pour faire le suivi de l'evolution d'une pathologie
US20090075956A1 (en) * 2005-04-07 2009-03-19 Nitromed, Inc. Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3
CA2610922A1 (fr) * 2005-06-13 2006-12-21 Yeda Research And Development Co. Ltd. Utilisation d'allylmercaptocaptopril pour traiter ou prevenir l'obesite et des maladies associees a l'obesite
US20090054381A1 (en) * 2005-10-04 2009-02-26 Nitromed, Inc. Methods for treating respiratory disorders
CN101443292B (zh) * 2006-03-14 2012-07-18 拉斯·E·古斯塔夫森 制备治疗化合物和组合物的新方法、用该方法制备的化合物和组合物，及其用途
US7625852B2 (en) * 2006-06-07 2009-12-01 Henry Hadry Nail polish remover
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
WO2009065142A2 (fr) 2007-11-15 2009-05-22 Biomedical Research Foundation Of Northwest Louisiana Utilisation de sels de nitrite dans l'ischémie chronique
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US20120237617A1 (en) 2009-06-18 2012-09-20 Theravasc Inc. Use of nitrite salts in treating tissue damage
IN2012DN03428A (fr) 2009-10-14 2015-10-23 Theravasc Inc
US20110160200A1 (en) * 2009-11-23 2011-06-30 Cardioxyl Pharmaceuticals, Inc. Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
MX356796B (es) * 2009-12-07 2018-06-14 Cardioxyl Pharmaceuticals Inc Derivados de hidroxilamina bis-acilados.
WO2011071951A2 (fr) * 2009-12-07 2011-06-16 Johns Hopkins University Dérivés de n-acyloxysulfonamide et de n-hydroxy-n-acylsulfonamide
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
ES2797649T3 (es) 2011-07-12 2020-12-03 Icu Medical Inc Dispositivo para entrega de agente antimicrobiano en un catéter transdérmico
BR112015003733A2 (pt) * 2012-08-23 2017-07-04 Cardiolynx Ag composições de liberação estendida de um nitrato de aminoalquila
JP2016509030A (ja) 2013-02-20 2016-03-24 セラバスク インコーポレーテッド ニトライトの医薬製剤及びそれらの使用
EP4219679A3 (fr) 2014-04-15 2023-08-09 Aobiome LLC Souche d23 de nitrosomonas eutropha oxydant l'ammoniac
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
WO2015168677A1 (fr) 2014-05-02 2015-11-05 Excelsior Medical Corporation Emballage de bande pour bouchon antiseptique
AU2016262400B2 (en) 2015-05-08 2021-01-21 Icu Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
ES2929769T3 (es) 2016-10-14 2022-12-01 Icu Medical Inc Tapas desinfectantes para conectores médicos
WO2018204206A2 (fr) 2017-05-01 2018-11-08 Icu Medical, Inc. Raccords de fluide médical et procédés pour fournir des additifs dans des conduites de fluide médical
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
EP3883638A1 (fr) 2018-11-21 2021-09-29 ICU Medical, Inc. Dispositif antimicrobien comprenant un capuchon avec bague et insert
GB2579240B (en) * 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007929D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New medical uses
WO2022072663A1 (fr) * 2020-10-01 2022-04-07 Emergent Product Development Gaithersburg Inc. Compositions stabilisées de nitrite d'alkyle
CA3204371A1 (fr) 2020-12-07 2022-06-16 Icu Medical, Inc. Capuchons, systemes et procedes de dialyse peritoneale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3106511A (en) * 1961-12-14 1963-10-08 Revlon Amyl nitrite inhalant composition
CA1163195A (fr) * 1980-06-26 1984-03-06 Alec D. Keith Milieu de diffusion polymerique contenant un vasodilatateur
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
DE3305690A1 (de) * 1983-02-18 1984-08-30 Heinrich Mack Nachf., 7918 Illertissen Glycerinmononitrate zur behandlung der angina pectoris
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4681584A (en) * 1985-05-03 1987-07-21 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
JPH06696B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
JPH06697B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition

Also Published As

Publication number Publication date
MX9303982A (es) 1994-02-28
US5278192A (en) 1994-01-11
OA09890A (en) 1994-09-15
CA2116785A1 (fr) 1994-01-20
PL302613A1 (en) 1994-09-05
AU4658793A (en) 1994-01-31
KR0170789B1 (ko) 1999-02-01
US5489610A (en) 1996-02-06
CN1086997A (zh) 1994-05-25
CZ39894A3 (en) 1994-11-16
CA2116785C (fr) 1998-04-07
JPH06510800A (ja) 1994-12-01
AU667948B2 (en) 1996-04-18
EP0604642A1 (fr) 1994-07-06
WO1994001103A1 (fr) 1994-01-20
TW261530B (fr) 1995-11-01
NZ254490A (en) 1997-08-22
NO305886B1 (no) 1999-08-16
JP2729333B2 (ja) 1998-03-18
ZA934771B (en) 1994-01-20
HU9400627D0 (en) 1994-06-28
NO940691L (no) 1994-03-18
IL106217A0 (en) 1993-11-15
NO940691D0 (no) 1994-02-28
SK23594A3 (en) 1994-08-10
HUT70501A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
US5489610A (en) Sustained release organic nitrite therapy
Boden et al. Nifedipine-lnduced hypotension and myocardial ischemia in refractory angina pectoris
ES2340939T3 (es) Utilizacioin del treprostinil para tratar las ulceras de pie diabeticas neuropaticas.
US20090203792A1 (en) Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators
JP3119430B2 (ja) 水酸基ラジカル消去剤
JPS5888312A (ja) カルニチンまたは低級アシルカルニチンからなる静脈疾患治療剤
US20230087361A1 (en) Use of dianthrone compound in preparation of medicament for prevention and/or treatment of myocardial ischemic disease and related disease thereof
RU2306924C1 (ru) Способ коррекции эндотелиальной дисфункции комбинацией лозартана и резвератрола при l-name-индуцированном дефиците оксида азота
RU2302241C1 (ru) Способ коррекции эндотелиальной дисфункции комбинацией индапамида и резвератрола при l-name-индуцированном дефиците оксида азота
US4148920A (en) Therapeutic L- and DL- phenylglycines to treat diseases or disorders of reduced blood flow or oxygen availability
RU2245147C2 (ru) Применение ингибитора вазопептидазы для лечения стенокардии
SU1664323A1 (ru) Кардиопротекторное средство "Милдронат
US4179521A (en) L- and DL-Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism
JPS60155115A (ja) 血圧上昇剤
US4179520A (en) L- and DL-Phenylglycines to treat a disease or condition attributable to reduced blood flow
US5326774A (en) Pharmaceutical preparation of antihypertensive, antianginal, antiarrhythmic and antiglaucomic action
LEVY Drugs in the treatment of heart disease
JPS61200917A (ja) ベタキソロールとニフエジピンとを含有する医薬組成物
EP1621193A2 (fr) Traitement de troubles non-douloreux de la vessie avec des modulateurs du canal calcique de la subunité alpha2-delta
Atkins Nitroglycerin explosions, tolerance, and myths
JPH03251540A (ja) 血管拡張剤
CA2277479A1 (fr) Utilisation de diadenosine polyphosphates pour reduire la pression sanguine
JPS59204119A (ja) 心筋梗塞症治療用製剤
ZA200505142B (en) Methods of treating non-painful bladder disorders using &2.d subunit calcium channel modulators
WO1996005819A1 (fr) Remede contre l'hypertension portale

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force